Drug Trial Radar · NCT06564818
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
223
Actual
Start
Dec 17, 2024
Primary completion
Sep 4, 2026
Study completion Oct 23, 2026
Sponsor
- Lead sponsor
- Cybin IRL LimitedIndustry
- Sponsor type
- Industry
- First posted
- Aug 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD.
Conditions
- Major Depressive Disorder
Interventions
CYB003Drug
CYB003 is a Deuterated Psilocin Analog.
Psychological SupportBehavioral
Manualized psychological support performed by facilitators
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Montgomery-Åsberg Depression Rating Scale (MADRS)Time frame: Screening Day-45, Baseline Day-1, Day 2, Day 10, Day 21, Day 23, Day 31, and Day 42 (End of Treatment)
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Scottsdale Research Institute
Phoenix, Arizona
Mountain Clinical Trials
Phoenix, Arizona
Noble Clinical Research
Tucson, Arizona
Del Sol Research Management
Tucson, Arizona
CenExel CIT (Clinical Innovations, Inc)
Bellflower, California
Kadima Neuropsychiatry Institute
La Jolla, California
Bespoke Treatment/Lipov Medical Group
Los Angeles, California
Catalina Research Institute
Montclair, California
Excell Research, Inc
Oceanside, California
Open Mind Therapeutics
San Francisco, California
Inland Psychiatric Medical Group Inc
San Juan Capistrano, California
Mountain View Clinical Research
Denver, Colorado
Starlight Clinical Research
Evergreen, Colorado
Research Centers of America
Hollywood, Florida
K2 Medical Research-Maitland
Maitland, Florida
Floridian Neuroscience Institute
Miami, Florida
Segal Trials West Broward
North Miami, Florida
Clinical Neuroscience Solutions, Inc
Orlando, Florida
Charter Research
Orlando, Florida
Combined Research Orlando Phase I-IV
Orlando, Florida
K2 Medical Research - Tampa
Tampa, Florida
Atlanta Center for Medical Research, CenExel
Atlanta, Georgia
CenExel iResearch Atlanta
Decatur, Georgia
CenExel iResearch Savannah
Savannah, Georgia
Great Lakes Clinical Trials, DBA Flourish Research
Chicago, Illinois
Uptown Research Institute
Chicago, Illinois
Psychiatric Medicine Associates, LLC
Skokie, Illinois
DelRicht Research
New Orleans, Louisiana
Sunstone Medical, PC
Rockville, Maryland
Adams Clinical Boston
Boston, Massachusetts
Adams Clinical
Boston, Massachusetts
Elixia Health
Springfield, Massachusetts
Redbird Research, LLC
Las Vegas, Nevada
Oasis Clinical Trials
Las Vegas, Nevada
Global Medical Institutes, Princeton Medical Institute
Princeton, New Jersey
Adams Clinical Harlem
New York, New York
Adams Clinical Bronx
The Bronx, New York
Monroe Biomedical Research
Monroe, North Carolina
Neurobehavioral Clinical Research
North Canton, Ohio
Adams Clinical Philadelphia
Philadelphia, Pennsylvania
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.